menu
{ "item_title" : "Multiple Myeloma", "item_author" : [" Thomas Moehler", "Hartmut Goldschmidt "], "item_description" : "Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy, including in particular the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life.", "item_img_path" : "https://covers1.booksamillion.com/covers/bam/3/54/085/771/3540857710_b.jpg", "price_data" : { "retail_price" : "169.99", "online_price" : "169.99", "our_price" : "169.99", "club_price" : "169.99", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
Multiple Myeloma|Thomas Moehler

Multiple Myeloma

local_shippingShip to Me
In Stock.
FREE Shipping for Club Members help

Overview

Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy, including in particular the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life.

This item is Non-Returnable

Details

  • ISBN-13: 9783540857716
  • ISBN-10: 3540857710
  • Publisher: Springer
  • Publish Date: April 2011
  • Dimensions: 9.2 x 6.5 x 1.1 inches
  • Shipping Weight: 1.45 pounds
  • Page Count: 340

Related Categories

You May Also Like...

    1

BAM Customer Reviews